Sm-EDTMP
Phase 2Terminated 0 views this week 0 watching💤 Quiet
Interest: 24/100
24
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Metastatic Osteosarcoma
Conditions
Metastatic Osteosarcoma
Trial Timeline
Aug 19, 2013 → Jun 11, 2017
NCT ID
NCT01886105About Sm-EDTMP
Sm-EDTMP is a phase 2 stage product being developed by Jazz Pharmaceuticals for Metastatic Osteosarcoma. The current trial status is terminated. This product is registered under clinical trial identifier NCT01886105. Target conditions include Metastatic Osteosarcoma.
What happened to similar drugs?
20 of 20 similar drugs in Metastatic Osteosarcoma were approved
Approved (20) Terminated (8) Active (0)
Hype Score Breakdown
Clinical
12
Activity
0
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01886105 | Phase 2 | Terminated |
Competing Products
20 competing products in Metastatic Osteosarcoma